Compared to naïve IMCs, MDSCs from tumor-bearing mice demonstrate increased levels of STAT3 activation (168), and JAK2/STAT3 pathway plays an essential role in MDSC expansion from hematopoietic progenitor cells. This evidence concerns the gene STAT3 and neoplasm.